Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity
- 2 October 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 83 (1) , 89-98
- https://doi.org/10.1189/jlb.0507300
Abstract
We reported previously that N-myc downstream-regulated gene 2 (NDRG2), a member of a new family of differentiation-related genes, is expressed specifically in dendritic cells (DC) differentiated from monocytes, CD34+ progenitor cells, and the myelomonocytic leukemic cell line. In this study, we demonstrate that NDRG2 protein expression is detected, not only in in vitro-differentiated DC but also in primary DC from lymph nodes, thymus, and skin when anti-NDRG2 antibodies are used. As predicted from previous studies investigating the mRNA expression pattern of several types of cell lines, progenitor cells, and DC, NDRG2 protein was expressed strongly in DC. Its expression was detected at significant levels after differentiation from progenitor cells. RNA interference of NDRG2 demonstrated that activated leukocyte cell adhesion molecule (ALCAM) expression is down-regulated specifically in DC differentiated from NDRG2 small interfering RNA (siRNA)-transfected monocytes. This was consistent with our observation that U937 cells transfected with NDRG2 became resistant to the GM-CSF/IL-4-induced ALCAM reduction. Furthermore, DC, which had differentiated from NDRG2 siRNA-transfected monocytes, showed a reduced ability to induce T cell proliferation. Taken together, our results indicate that NDRG2 is able to preserve ALCAM expression during DC differentiation from monocytes under cytokine culture conditions and that its expression helps DC maintain costimulatory signals necessary for T cell stimulation.Keywords
Funding Information
- Korea Science and Engineering Foundation (R11-2005-017-03001)
- Korea Research Foundation (KRF-2006-311-E00586)
- Korean Food and Drug Administration (05092-CEL-326)
This publication has 36 references indexed in Scilit:
- Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsBlood, 2006
- Frontline: Optimal T cell activation requires the engagement of CD6 and CD166European Journal of Immunology, 2004
- Potential roles of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines: Augmentation of differentiation via prolonged activation of extracellular signal-regulated kinaseExperimental Hematology, 2002
- Activated leukocyte cell adhesion molecule (CD166/ALCAM): Developmental and mechanistic aspects of cell clustering and cell migrationEuropean Journal of Cell Biology, 2002
- The Immunological SynapseAnnual Review of Immunology, 2001
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Signal extinction and T cell repolarization in T helper cell‐antigen‐presenting cell conjugatesEuropean Journal of Immunology, 1996
- Responses of T cells to ligands for the T-cell receptorSeminars in Immunology, 1996
- A Role for CD5 in TCR-Mediated Signal Transduction and Thymocyte SelectionScience, 1995
- Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.The Journal of Experimental Medicine, 1995